Mmastodon BusinessMarkets first seen 1 d ago, last 2 min ago, peak #1
Kobayashi Pharmaceutical may be target of ¥500 billion buyout
Original: Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese company at the center of a supplement contamination scandal involving suspected deaths, is reportedly considering a potential buyout offer valued at more than ¥500 billion. The news puts the embattled Osaka-based drugmaker back in the spotlight, with attention on who might take over the firm and what it would mean for the company's future after the scandal damaged its reputation and finances.
Why now: Reports of a potential buyout of a scandal-hit drugmaker signal a major shift in its corporate future.
Rank over time, top of the chart is #1. 23 snapshots from 1 d ago to 2 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/18193